LONDON: Mendell Helium has announced the conditional disposal of its plant-based health & wellness business, Voyager, to Orsus Therapeutics plc, a private label turnkey solutions provider specialising in developing, formulating, marketing & sales of health and wellness products for global brands. 

As announced on 27 June 2024, the company has an option to acquire M3 Helium Corp., a producer of helium based in Kansas and with an interest in six wells. 

There is no certainty that the Company’s option to acquire M3 Helium will be exercised, nor that the enlarged group will successfully complete its re-admission to trading on the AQSE Growth Market.

Voyager’s plant-based health and wellness operations comprise manufacturing facility in Perth, Scotland producing both products for own brand and third party customers (VoyagerCann); e-commerce and wholesale operations based in Perth, Scotland; ehree brands: Voyager, Ascend Skincare and Amphora; and three retail stores in Scotland.

Nick Tulloch, Chief Executive Officer of Mendell Helium, said: “We are delighted to announce the conditional disposal of our plant based health & wellness business with Orsus.  Voyager is four years old and, in that time, has established three brands within the UK’s CBD market and, most importantly through VoyagerCann, a reputation for high quality manufacture of white label and third party products.  We have several high profile and substantial customers which we believe will grow their product range over the coming months and years.

“A key attraction of the combination with Orsus is that we are working with people we know and who have particular expertise in the health & wellness market.  Orsus has already put in place plans to invest in and expand the business and, through the terms of the Disposal, our shareholders stand to benefit from the enlarged operations.  In time we aim to transfer the shares and warrants we receive in Orsus to our shareholders thereby giving them interests in both our potential new helium operations as well as our enlarged health & wellness business.”

Dr Adi Zuloff-Shani, Chair of Orsus Therapeutics, said: “The acquisition of Mendell Helium’s plant-based health and wellness business not only enhances Orsus’ portfolio but also positions us to establish a world-class facility in Perth, Scotland as our base to serve brands globally. By merging the Voyager team with ours , we will leverage our joint expertise and comprehensive understanding of market trends to provide turnkey solutions for global health and wellness brands across various categories. Through meticulous design, expert formulation, rapid manufacturing and stringent quality control, our commitment to excellence and innovation remains steadfast as well as todelivering exceptional products for our clients.”

Voyager Life secures option to acquire M3 Helium Corp. based in Kansas